FENFLURAMINE AND METHYLPHENIDATE IN CHILDREN WITH MENTAL RETARDATION AND BORDELINE IQ: CLINICAL EFFECTS
Shranjeno v:
AMAN, M.G., ET AL., FENFLURAMINE AND METHYLPHENIDATE IN CHILDREN WITH MENTAL RETARDATION AND BORDELINE IQ: CLINICAL EFFECTS. AMERICAN JOURNAL ON MENTAL RETARDATION, Vol. 101, no. 5 (1997), p. 521-534.
Ref.
63236
Lokacija:
SIIS R.100
Palabras clave:
Discapacidad, Discapacidad intelectual, Fármacos, Hiperactividad, Trastornos de atención, Tratamiento
Discapacidad, Discapacidad intelectual, Fármacos, Hiperactividad, Trastornos de atención, Tratamiento
Podobne knjige/članki: FENFLURAMINE AND METHYLPHENIDATE IN CHILDREN WITH MENTAL RETARDATION AND BORDELINE IQ: CLINICAL EFFECTS
- FENFLURAMINE AND METHYLPHENIDATE IN CHILDREN WITH MENTAL RETARDATION AND ADHD: CLINICAL AND SIDE EFFECTS
- FENFLURAMINE AND METHYLPHENIDATE IN CHILDREN WITH MENTAL RETARDATION AND ATTENTION DEFICIT HYPERACTIVITY DISORDER: LABORATORY EFFECTS
- A CONTROLLED CASE STUDY OF METHYLPHENIDATE AND FENFLURAMINE IN A YOUNG MENTALLY RETARDED, HYPERACTIVE CHILD
- PREDICTION OF CLINICAL RESPONSE IN CHILDREN TAKING METHYLPHENIDATE
- EFFECTS AND NONEFFECTS OF METHYLPHENIDATE IN CHILDREN WITH MENTAL RETARDATION AND ADHD
- LONG-TERM FOLLOW-UP OF CHILDREN WITH MENTAL RETARDATION-BORDELINE INTELLECTUAL FUNCTIONING AND ADHD